Amine oxidase mutant for improving content of myosmin in tobacco leaves and application of amine oxidase mutant
By genetically engineering mutant amine oxidase, the content of mesmin in tobacco leaves is increased, the problem of low amine oxidase activity in the prior art is solved, and efficient catalytic production and cost reduction of mesmin is achieved.
Patent Information
- Application Number
- CN202411285612.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-13
- Publication Date
- 2024-12-03
AI Technical Summary
The existing amine oxidase activity is low and cannot effectively increase the mesmin content during the tobacco leaf alcoholization process, which limits the improvement of tobacco leaf quality and the reduction of production costs.
Through genetic engineering, mutated the amine oxidase gene, an amine oxidase mutant with significantly improved enzyme activity was obtained, and the corresponding engineering strain was constructed, with increased expression, and expressed in E. coli using the pET-28a(+) plasmid to induce expression in E. coli to induce expression And whole-cell catalysis was performed to increase the yield of mesmin.
The enzyme activity of the mutant increased by 42%, and maintained 90% of the enzyme activity under acidic conditions. The yield reached 31.2 g/L after 15 hours of catalytic time, which significantly increased the content of mezine in tobacco leaves and reduced production costs.
Smart Images

Figure CN119060971A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biochemical engineering and genetic engineering, and specifically relates to an amine oxidase mutant with increased myosamine content and application thereof. Background Art
[0002] Cinnabar tobacco is a natural variation of fine tobacco varieties during the growth process. After normal conditioning, the structure is loose, the front of the leaf is red or red, and it looks like a "cat's paw print", commonly known as "Cinnabar" tobacco. It is called "cherry red" abroad, and its color is similar to cherries. It is the best high-quality tobacco raw material for developing high-end brands of Chinese cigarettes. Cinnabar tobacco is called "cherry red tobacco" abroad. It was first reported in the 1950s and has received continuous attention from the cigarette industry for its special "glutinous rice fragrance" flavor. The characteristics of Cinnabar tobacco leaves are low in nicotine content and high in demethyl nicotine and mesamine. Li Yong et al. used simultaneous distillation-gas chromatography-mass spectrometry to analyze the characteristics of aroma substances in Cinnabar tobacco and ordinary tobacco leaves. The results showed that the substances represented by mesamine in Cinnabar tobacco increased by dozens of times compared with ordinary tobacco leaves. Therefore, the targeted metabolism of nicotine into mesamine is of great significance to improving the quality of tobacco leaves and has certain economic value.
[0003] Patent CN202210169763.3 discloses a method of synthesizing myosamine by chemical method using pyridine aldehyde and ketone compounds and bromonitrile as raw materials. Although it has the advantages of low cost and high efficiency, it cannot be applied to the synthesis of myosamine in tobacco leaves. Research in recent years has focused on the synthesis of (S)-nornicotine (s-nicotine) from myosamine by catalysis of imine reductase, dehydrogenase, etc. The conversion of nornicotine to myosamine can further promote the transformation of ordinary tobacco leaves to cinnabar tobacco, thereby improving the quality of tobacco leaves.
[0004] The amine oxidase activity reported in the literature is currently low and cannot play an effective role in the tobacco leaf aging process, thus limiting its use. Further separation and purification of the enzyme not only increases production costs but also limits the level of quality improvement, which is the main issue to be considered in industrial production. Summary of the invention
[0005] The purpose of the present invention is to provide an amine oxidase mutant for increasing the myosamine content in tobacco leaves and its application. By genetically engineering the amine oxidase gene, an amine oxidase mutant with significantly improved enzyme activity is obtained, and by constructing a corresponding engineered strain, the expression level is increased, which is of great significance for obtaining industrial enzyme preparations, meeting the needs of industrial production, and reducing production costs.
[0006] To achieve the above objectives, this application is implemented through the following technical solutions: The invention discloses an amine oxidase mutant for increasing the mycosamine content in tobacco leaves. The amine oxidase is derived from Klebsiella. The amino acid sequence of the amine oxidase encoding gene is shown in SEQ ID NO: 1. In the amino acid sequence, the phenylalanine at position 192 is mutated to glutamine, the threonine at position 299 is mutated to aspartic acid, and the arginine at position 313 is mutated to glutamic acid.
[0007] Furthermore, the amino acid sequence of the gene encoding the amine oxidase mutant is shown in SEQ ID NO:3.
[0008] Furthermore, an engineered bacterium expressing a gene encoding a recombinant amine oxidase mutant.
[0009] Furthermore, the engineered bacteria uses pET-28a(+) plasmid as an expression vector and Escherichia coli as an expression host.
[0010] Furthermore, the host is Escherichia coli BL21 (DE3) or MG1655 (DE3).
[0011] Furthermore, the method for obtaining the amine oxidase mutant is to connect the gene fragment encoding the mutant to an expression vector and transform Escherichia coli for expression.
[0012] An application, any of the above items relates to the use of amine oxidase mutants in increasing mycosamine in tobacco leaves.
[0013] Furthermore, when the engineered bacteria are cultured to OD600 = 0.6-0.8, IPTG with a final concentration of 0.2-1.0 mM is added to induce expression.
[0014] Furthermore, the induction conditions were 20 °C, 200 RPM, and 10-14 h.
[0015] Furthermore, the induced engineered bacterial solution is sprayed at a spraying rate of 1%-10%.
[0016] The beneficial effects of the present invention are: A highly active amine oxidase mutant was obtained by iterative saturation mutation. The mutant mutated the phenylalanine at position 192 of the amine oxidase shown in the amino acid sequence of SEQ ID NO:1 to glutamine, the threonine at position 299 to aspartic acid, and the arginine at position 313 to glutamic acid. The mutant has higher enzyme activity and a catalytic efficiency of 42%. In addition, the enzyme activity is stable at pH 5.5-pH 9.5; the relative enzyme activity is still about 90% for 10 hours under acidic conditions. Under pH 5.5, the amine oxidase mutant of the present invention can also maintain more than 85% of the enzyme activity, and greatly improves the yield of enzyme-catalyzed preparation of myosamine. After whole-cell catalysis test, the level of myosamine produced after 15 hours of catalysis is 31.2 g / L, which has certain value for the tobacco alcoholization process. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 is the relative enzyme activity of mutant amine oxidase and wild-type amine oxidase under different pH conditions.
[0018] Figure 2 is the relative enzyme activity of mutant amine oxidase and wild-type amine oxidase under different time conditions.
[0019] Figure 3 This is the yield of mysamine after 20 h of whole cell catalysis. DETAILED DESCRIPTION
[0020] The preferred embodiment of the present invention will be described clearly and completely below in conjunction with the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention. The experimental methods for which specific conditions are not specified in the embodiments are usually carried out under conventional conditions or under conditions recommended by the manufacturer.
[0021] Example 1 Construction of recombinant plasmid pET28a-DEII: DEII gene, primer synthesis and sequencing in the present invention were completed by Qingke Biotechnology Co., Ltd. DEII gene fragment in pUC57-DEII was amplified with DEII-F and DEII-R as primers, and its size was 1302 bp. The purified DEII gene fragment was homologously recombined with pET-28a (+) linearized vector cut with BamHI and EcoRI, and the ligation product was transformed into E. coli BL21(DE3) competent cells. The transformed strains cultured overnight were selected for colony PCR verification. After successful verification, they were sent for sequencing analysis. The sequencing results were analyzed by SnapGene 6.0.2 software. The strains with correct sequencing were named E. coli pET28a-DEII; wherein the primers are as follows: DEII-F: ATGGGTCGCGGATCATGGGCGAAGTATTCGATGTTGC; DEII-R: ACGGAGCTCGAATTCTATAGTCTCTGTTTGTTTAGCTTGATAAAGACGT.
[0022] Example 2 Construction and verification of site-directed mutagenesis plasmid amplification: The plasmid pET28a-DEII prepared in Example 1 was used as a template, and the Mut II Fast Mutagenesis Kit V2 kit of Nanjing Novogene Biotech Co., Ltd. was used to amplify the site-directed mutation plasmid pET28a-DEII by homologous recombination in vitro. F192Q / T299D / R313E , that is, the amino acid sequence of the amine oxidase shown in SEQ ID NO: 1 has the phenylalanine at position 192 mutated to glutamine, the threonine at position 299 mutated to aspartic acid, and the arginine at position 313 mutated to glutamic acid, and the amino acid sequence after the three-point mutation is shown in SEQ ID NO: 3. pET28a-DEII F192Q / T299D / R313E The primers used for site-directed mutagenesis are as follows: F192Q-F: 5'-TTCAGTGCTTTTGTTGAAACGGCCGGC-3'; F192Q-R: 5'-CCAAGTGCCCGGCCGTTTCAACAAAGCA-3'; T299D-F: 5'-ATCAAACCCTTTGACATCTACGCACCAGCT-3'; T299D-R: 5'-TCCCAGCTGGTGCGTAGATGTCAAAGGGTT-3'; R313E-F: 5'-TCAATGCCGCGGAGACGGAGAAGTACTTTG-3'; R313E-R: 5'-CCATCAAAGTACTTCTCCGTCTCCGCGGC-3'; Using pET28a-DEII as template, the first round of in vitro amplification was performed with the site-directed mutagenesis primers at the F192Q site. The PCR amplification conditions were: 95°C for 30 s; 95°C for 15 s, 68°C for 7 min, 72°C for 3 min, 30 cycles; 72°C for 10 min, 4°C for 5 min, and then ended. After the third round, the PCR product pET28a-DEII was taken. F192Q / T299D / R313E10 mL of plasmid was added with 1 mL of DpnI restriction enzyme and digested at 37 °C for 1 h. Agarose gel electrophoresis was performed for preliminary verification and gel recovery was performed using a DNA recovery kit. According to the concentration, 100 ng of pET28a-DEII was taken. F192Q / T299D / R313E Transform the plasmid into E. coli DH5α competent cells were plated on LB plates (containing 50 mg / L kanamycin sulfate). After constant temperature culture for 12-16 h, single colonies on the plates were picked for colony PCR, and positive clones were selected for verification by gene sequencing. The results showed that the correct mutant plasmid was obtained. Mutant pET28a-DEII F192Q / T299D / R313E The specific amino acid sequence is shown in SEQ ID NO:3, and the nucleotide sequence is shown in SEQ ID NO:4. Example 3
[0023] The correct mutant plasmid obtained in Example 2 was transformed into E. coli BL21 (DE3) competent cells were spread on LB (containing 50 mg / L kanamycin sulfate) plates, and the plates were inverted and cultured in a 37 °C incubator overnight. Then, a single colony was picked and placed in a liquid medium supplemented with kanamycin resistance, and cultured at 37 °C and 220 RPM overnight; 1% (v / v) inoculation was inoculated into 50 mL LB liquid medium supplemented with 50 mg / L kanamycin resistance, and cultured at 37 °C and 220 RPM. When the recombinant bacteria grew to OD 600 =0.6-0.8, add IPTG to a final concentration of 0.2 mmol / L, and then induce expression at 20 ℃ and 200 RPM for 10-14 h. After induction, collect the cells by centrifugation and discard the supernatant. Resuspend the cell pellet in PBS buffer with a pH of 7.0, ultrasonically disrupt, and centrifuge to remove protein fragments to obtain a crude enzyme solution. Example 4
[0024] Enzymatic properties of amine oxidase mutants: (1) Optimum pH: The crude enzyme solution obtained in Example 4 was used as a mutant amine oxidase sample, and the amine oxidase constructed with the nucleotide sequence as shown in SEQ ID NO: 2 E. coli pET28a-DEII F192Q / T299D / R313E The crude enzyme solution of the strain was used as the control sample, and the highest enzyme activity of the amine oxidase mutant was used as the benchmark. The relative enzyme activity was determined at different pH values of 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, and 9.5 at 37°C. Figure 1It can be seen that the lysine decarboxylase mutant of the present invention has relatively stable enzyme activity in the range of pH 5.5-9.5, and the optimum pH is 6.0. The above results show that compared with before mutation, the amine oxidase after mutation of the present invention has higher enzyme activity under lower acidic conditions, its pH range of action is wider, and it can further increase the yield of myosamine.
[0025] The enzyme activity of amine oxidase is defined as: the amount of enzyme required to produce 1 mmol of mycosamine per minute is 1 U.
[0026] Enzyme activity reaction system: Take a certain amount of crude enzyme solution, add 100 mM (S)-nornicotine, react at 37 ℃ and 220 rpm for 1 h, and then detect the myosamine concentration.
[0027] (2) Optimum reaction temperature: The crude enzyme solution obtained in Example 4 was used as a mutant amine oxidase sample, and the amine oxidase constructed with the nucleotide sequence as shown in SEQ ID NO: 2 E. coli pET28a-DEII F192Q / T299D / R313E The crude enzyme solution of the strain was used as the control sample. The highest enzyme activity of the amine oxidase mutant was used as the benchmark. The enzyme activity at different temperatures of 15 ℃, 20 ℃, 25 ℃, 30 ℃, 35 ℃, 40 ℃, 45 ℃, and 50 ℃ was measured at pH 6.0. The relative enzyme activity was calculated. The results are shown in Figure 2 As shown, the amine oxidase mutant of the present invention has stable enzyme activity at 20-40°C, and the optimum action temperature is 25°C. Compared with the wild-type amine oxidase, the mutant can maintain more than 80% of the enzyme activity at 40°C. The above results show that compared with the amine oxidase before mutation, the amine oxidase after mutation of the present invention still has higher enzyme activity at higher temperature.
[0028] The enzyme activity of amine oxidase is defined as: the amount of enzyme required to produce 1 mmol of mycosamine per minute is 1 U.
[0029] Enzyme activity reaction system: Take a certain amount of crude enzyme solution, add 100 mM (S)-nornicotine, react at 37°C and 220 RPM for 1 h, and then detect the myosamine concentration. Example 5
[0030] Myosamine production by wild-type and mutant engineered strains: The recombinant bacteria obtained in Example 3 were used as production strains; LB liquid kanamycin resistance medium: peptone 10.0 g / L, yeast extract 5.0 g / L, NaCl 10.0 g / L, agar 16.0 g / L, kanamycin 50 mg / L, 121 ℃, sterilization for 20 min; A suitable amount of activated single colonies of each engineered bacterium were inoculated into 100 mL LB liquid medium containing kanamycin resistance, and cultured at 37 °C, 220 RPM for 12 h. Then, 5% (v / v) of the strain was transferred to a 5 L fermenter containing 2 L fermentation medium. The culture temperature was 37 °C, the stirring speed was 200-500 RPM, and the air flow rate was 1-4 vvm , in OD 600 When the reaction temperature reached 30, 0.2 mM IPTG was added to induce the expression of amine oxidase for 10 h, and 10 g / L (S)-demethylnicotine was added and fed to maintain its concentration at 5 g / L. The stirring speed was controlled at 300-450 RPM, the reaction temperature was 20-25 °C, and the reaction cycle was 20 h to complete the catalysis.
[0031] The above enzyme catalysis method was used for the experiment with a reaction time of 20 h. The production of myosamine is shown in Table 1. The average myosamine production level is 31.2 g / L, indicating that the strain not only produces a high amount of amine oxidase but also has a certain stability in its catalytic performance and the enzymatic activity of the amine oxidase it produces.
[0032] Table 1 Catalytic production of three batches of engineered strains
[0033] Comparative Example 1 The specific implementation method is as in Example 5, except that IPTG is not used for induction, and the subsequent experimental steps are the same. The yield of myosmin produced by the strain under the same catalytic conditions was detected, and the results showed that without IPTG induction, the yield of myosmin could only reach 3.7 g / L within 20 h.
[0034] Comparative Example 2 The specific implementation method is as in Example 5, except that the amine oxidase that has not been mutated is used for catalysis, and the other experimental steps are the same as in Example 5. The metabolic ability of the original enzyme to demethylated nicotine is detected under the same catalytic conditions. The results show that under the catalysis of the original amine oxidase, the yield of myosamine gradually increases, but under the catalytic reaction of 20 h, the content of myosamine can only reach 17.9 g / L, which is far less than the effect of the mutant enzyme. It can be seen that the mutant of the amine oxidase proposed in the present invention has a significantly improved metabolic conversion effect on demethylated nicotine.
[0035] Comparative Example 3 Specific implementation method is as in Example 5, except that the amount of enzyme added is changed, and the ability to produce mysamine is tested at 10 and 30 U / mL of enzyme added. The results show that at 10 and 30 U / mL of enzyme added, nornicotine can be metabolized to mysamine, but its conversion efficiency is not high. Within 20 hours, the yield of mysamine reaches 19.8 g / L and 22.5 g / L, respectively.
[0036] Finally, it should be noted that the above preferred embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail through the above preferred embodiments, those skilled in the art should understand that various changes can be made in form and details without departing from the scope defined by the claims of the present invention.
Claims
1. An amine oxidase mutant for increasing the mycosamine content in tobacco leaves, wherein the amine oxidase is derived from Klebsiella, and the amino acid sequence of the amine oxidase encoding gene is shown in SEQ ID NO: 1, characterized in that: In the amino acid sequence, the phenylalanine at position 192 mutated to glutamine, the threonine at position 299 mutated to aspartic acid, and the arginine at position 313 mutated to glutamic acid.
2. The amine oxidase mutant for increasing the myosamine content in tobacco leaves according to claim 1, characterized in that: The amino acid sequence of the gene encoding the amine oxidase mutant is shown in SEQ ID NO:
3.
3. The amine oxidase mutant for increasing the myosamine content in tobacco leaves according to claim 1, characterized in that: An engineered bacterium expressing a gene encoding a recombinant amine oxidase mutant.
4. The amine oxidase mutant for increasing the myosamine content in tobacco leaves according to claim 3, characterized in that: The engineering bacteria uses pET-28a(+) plasmid as an expression vector and Escherichia coli as an expression host.
5. The amine oxidase mutant for increasing the myosamine content in tobacco leaves according to claim 4, characterized in that: The host is Escherichia coli BL21 (DE3) or MG1655 (DE3).
6. The amine oxidase mutant for increasing the myosamine content in tobacco leaves according to claim 5, characterized in that: The method for obtaining the amine oxidase mutant is to connect the amine oxidase mutant encoding gene fragment to an expression vector and transform Escherichia coli for expression.
7. An application, characterized in that: Any one of claims 1 to 6 above relates to the use of an amine oxidase mutant in increasing mycosamine in tobacco leaves.
8. The use according to claim 7, characterized in that: When the engineered bacteria are cultured to OD600 = 0.6-0.8, IPTG with a final concentration of 0.2-1.0 mM is added to induce expression.
9. The use according to claim 8, characterized in that The induction conditions were 20 °C, 200 RPM, and 10-14 h.
10. The use according to claim 8, characterized in that: The induced engineered bacterial solution is sprayed at a spraying rate of 1%-10%.
Citation Information
Cited By
Histamine oxidase protein and application thereof
CN121975758A
